BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

11956

543654

MEDANTA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

GLOBAL HEALTH LIMITED performance

Today’s low

Today’s high

₹ 1171.50 ₹ 1205.00
₹ 1197.20

52 week low

52 week high

₹ 935.50 ₹ 1511.00
₹ 1197.20

Open Price

₹ 1171.50

Prev. Close

₹ 1177.80

Volume (Shares)

292094.00

Total traded value

₹ 3496.94

Upper Circuit

₹ 1413.30

Lower Circuit

₹ 942.30

info

GLOBAL HEALTH LIMITED Share Price Update

As of the latest trading session, GLOBAL HEALTH LIMITED share price is currently at ₹ 1197.2, which is up by ₹ 19.39 from its previous closing. Today, the stock has fluctuated between ₹ 1171.50 and ₹ 1205.00. Over the past year, GLOBAL HEALTH LIMITED has achieved a return of -17.16 %. In the last month alone, the return has been -2.75 %. Read More...

GLOBAL HEALTH LIMITED fundamentals


  • Market cap (Cr)

    30,315.97

  • P/E Ratio (TTM)

    82.03

  • Beta

    0.75

  • Book Value / share

    113.49

  • Return on equity

    13.52%

  • EPS (TTM)

    14.61

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    99.31

info icon alternate text
  • Market cap (Cr)

    30,386.87

  • P/E Ratio (TTM)

    82.03

  • Beta

    0.70

  • Book Value / share

    113.49

  • Return on equity

    13.52%

  • EPS (TTM)

    14.61

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    99.31

info icon alternate text

GLOBAL HEALTH LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 624.40
Operating Expense 514.26
Net Profit 99.31
Net Profit Margin (%) 15.90
Earnings Per Share (EPS) 3.70
EBITDA 161.69
Effective Tax Rate (%) 24.94
Particulars SEP 2024 (Values in Cr)
Revenue 664.61
Operating Expense 544.58
Net Profit 104.47
Net Profit Margin (%) 15.71
Earnings Per Share (EPS) 3.89
EBITDA 173.89
Effective Tax Rate (%) 27.25
Particulars JUN 2024 (Values in Cr)
Revenue 611.45
Operating Expense 508.40
Net Profit 96.28
Net Profit Margin (%) 15.74
Earnings Per Share (EPS) 3.58
EBITDA 158.99
Effective Tax Rate (%) 25.79
Particulars MAR 2024 (Values in Cr)
Revenue 578.65
Operating Expense 486.03
Net Profit 92.24
Net Profit Margin (%) 15.94
Earnings Per Share (EPS) 3.43
EBITDA 154.76
Effective Tax Rate (%) 26.30
Particulars DEC 2023 (Values in Cr)
Revenue 564.84
Operating Expense 466.64
Net Profit 87.34
Net Profit Margin (%) 15.46
Earnings Per Share (EPS) 3.25
EBITDA 148.36
Effective Tax Rate (%) 27.74
Particulars MAR 2024 (Values in Cr)
Revenue 2280.01
Operating Expense 1894.21
Net Profit 360.89
Net Profit Margin (%) 15.82
Earnings Per Share (EPS) 13.44
EBITDA 600.22
Effective Tax Rate (%) 26.14
Particulars MAR 2023 (Values in Cr)
Revenue 1973.54
Operating Expense 1669.42
Net Profit 263.25
Net Profit Margin (%) 13.33
Earnings Per Share (EPS) 10.16
EBITDA 463.96
Effective Tax Rate (%) 25.15
Particulars MAR 2022 (Values in Cr)
Revenue 1764.96
Operating Expense 1504.15
Net Profit 218.79
Net Profit Margin (%) 12.39
Earnings Per Share (EPS) 8.68
EBITDA 410.58
Effective Tax Rate (%) 26.04
Particulars MAR 2021 (Values in Cr)
Revenue 1227.40
Operating Expense 1171.33
Net Profit 57.29
Net Profit Margin (%) 4.66
Earnings Per Share (EPS) 6.93
EBITDA 196.79
Effective Tax Rate (%) 32.14
Particulars MAR 2023 (Values in Cr)
Book Value / Share 90.54
ROE % 16.13
ROCE % 16.49
Total Debt to Total Equity 0.55
EBITDA Margin 25.44
Particulars MAR 2022 (Values in Cr)
Book Value / Share 63.82
ROE % 13.09
ROCE % 14.05
Total Debt to Total Equity 0.68
EBITDA Margin 22.91
Particulars MAR 2021 (Values in Cr)
Book Value / Share 272.22
ROE % 2.11
ROCE % 4.43
Total Debt to Total Equity 0.68
EBITDA Margin 15.78
Particulars MAR 2020 (Values in Cr)
Book Value / Share 266.90
ROE % 2.75
ROCE % 5.35
Total Debt to Total Equity 0.65
EBITDA Margin 15.69
Particulars MAR 2019 (Values in Cr)
Book Value / Share 257.06
ROE % 3.96
ROCE % 5.63
Total Debt to Total Equity 0.61
EBITDA Margin 15.28
Particulars MAR 2024 (Values in Cr)
Book Value / Share 106.10
ROE % 13.52
ROCE % 17.19
Total Debt to Total Equity 0.10
EBITDA Margin 26.59
Particulars MAR 2023 (Values in Cr)
Book Value / Share 92.80
ROE % 12.45
ROCE % 15.41
Total Debt to Total Equity 0.14
EBITDA Margin 23.80
Particulars MAR 2022 (Values in Cr)
Book Value / Share 68.70
ROE % 13.57
ROCE % 16.88
Total Debt to Total Equity 0.17
EBITDA Margin 23.56
Particulars MAR 2021 (Values in Cr)
Book Value / Share 292.65
ROE % 3.99
ROCE % 6.57
Total Debt to Total Equity 0.08
EBITDA Margin 16.40
Particulars MAR 2020 (Values in Cr)
Book Value / Share 281.74
ROE % 7.70
ROCE % 10.25
Total Debt to Total Equity 0.06
EBITDA Margin 17.80
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 511.80
Total Assets 3145.51
Total Liabilities 3145.51
Total Equity 1616.01
Share Outstanding 253223930
Price to Book Ratio 0.00
Return on Assets (%) 6.23
Return on Capital (%) 8
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 289.30
Total Assets 2694.10
Total Liabilities 2694.10
Total Equity 1382.34
Share Outstanding 49585818
Price to Book Ratio 0.00
Return on Assets (%) 1.06
Return on Capital (%) 1.42
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 250.12
Total Assets 2666.28
Total Liabilities 2666.28
Total Equity 1349.53
Share Outstanding 49345003
Price to Book Ratio 0.00
Return on Assets (%) 1.36
Return on Capital (%) 1.84
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 266.45
Total Assets 2430.00
Total Liabilities 2430.00
Total Equity 1295.49
Share Outstanding 49132778
Price to Book Ratio 0.00
Return on Assets (%) 2.11
Return on Capital (%) 2.85
Particulars MAR 2018 (Values in Cr)
Cash & Short Term Investments 260.20
Total Assets 1983.82
Total Liabilities 1983.82
Total Equity 1217.20
Share Outstanding 48494054
Price to Book Ratio 0.00
Return on Assets (%) 1.65
Return on Capital (%) 2.03
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 959.21
Total Assets 3523.37
Total Liabilities 3523.37
Total Equity 2848.79
Share Outstanding 268507382
Price to Book Ratio 12.48
Return on Assets (%) 10.24
Return on Capital (%) 12.41
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1144.82
Total Assets 3178.70
Total Liabilities 3178.70
Total Equity 2488.86
Share Outstanding 268195172
Price to Book Ratio 5.67
Return on Assets (%) 8.28
Return on Capital (%) 10.16
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 441.33
Total Assets 2361.33
Total Liabilities 2361.33
Total Equity 1739.75
Share Outstanding 253223930
Price to Book Ratio 0.00
Return on Assets (%) 9.26
Return on Capital (%) 11.75
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 254.77
Total Assets 2002.11
Total Liabilities 2002.11
Total Equity 1483.63
Share Outstanding 49585818
Price to Book Ratio 0.00
Return on Assets (%) 2.86
Return on Capital (%) 3.8
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 218.76
Total Assets 1957.89
Total Liabilities 1957.89
Total Equity 1422.72
Share Outstanding 49345003
Price to Book Ratio 0.00
Return on Assets (%) 5.24
Return on Capital (%) 7.13
Particulars MAR 2023 (Values in Cr)
Net Income 449.29
Cash from Operations 750.66
Cash from Investing -342.34
Cash from Financing 345.63
Net change in Cash 647.81
Free Cash Flow 986.64
Particulars MAR 2022 (Values in Cr)
Net Income 280.55
Cash from Operations 409.28
Cash from Investing -420.88
Cash from Financing 159.58
Net change in Cash 49.96
Free Cash Flow 683.75
Particulars MAR 2021 (Values in Cr)
Net Income 32.46
Cash from Operations 258.16
Cash from Investing -239.15
Cash from Financing -80.72
Net change in Cash -78.10
Free Cash Flow 403.90
Particulars MAR 2020 (Values in Cr)
Net Income 63.88
Cash from Operations 231.24
Cash from Investing -87.06
Cash from Financing -0.88
Net change in Cash 87.11
Free Cash Flow 419.51
Particulars MAR 2019 (Values in Cr)
Net Income 83.26
Cash from Operations 233.05
Cash from Investing -248.75
Cash from Financing 97.03
Net change in Cash 13.82
Free Cash Flow 532.74
Particulars MAR 2024 (Values in Cr)
Net Income 488.67
Cash from Operations 485.32
Cash from Investing -698.52
Cash from Financing -66.22
Net change in Cash -424.11
Free Cash Flow 671.66
Particulars MAR 2023 (Values in Cr)
Net Income 351.70
Cash from Operations 531.47
Cash from Investing -257.28
Cash from Financing 404.22
Net change in Cash 577.46
Free Cash Flow 647.49
Particulars MAR 2022 (Values in Cr)
Net Income 295.82
Cash from Operations 326.18
Cash from Investing -312.99
Cash from Financing 97.59
Net change in Cash 20.00
Free Cash Flow 390.76
Particulars MAR 2021 (Values in Cr)
Net Income 84.42
Cash from Operations 215.51
Cash from Investing -250.46
Cash from Financing -36.66
Net change in Cash -86.24
Free Cash Flow 241.80
Particulars MAR 2020 (Values in Cr)
Net Income 130.93
Cash from Operations 226.05
Cash from Investing -45.33
Cash from Financing -55.64
Net change in Cash 91.57
Free Cash Flow 243.36
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6962.05 76.41 13.35 100103.60 5690.80 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 75.38 183.85 4.73 141.28 51.01 / 98.70
SHREE PACETRONIX LTD. 70.00 14.58 1.87 25.20 61.11 / 268.50
TRANSGENE BIOTEK LTD. 3.68 0.00 2.57 27.88 3.22 / 10.84
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6962.05 83.30 12.22 100103.60 5690.80 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 32.25 0.00 -17.27 24.09 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5560.50 29.47 6.24 6083.19 3750.00 / 6400.00

GLOBAL HEALTH LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1197.20 1.64 redarrow
red-green-graph indicator
12 Bearish
4 Bullish
  • 5 Days 1206.70
  • 26 Days 1225.40
  • 10 Days 1221.70
  • 50 Days 1204.40
  • 12 Days 1224.70
  • 100 Days 1173.20
  • 20 Days 1227.80
  • 200 Days 1142.60
1190.53 PIVOT

First Support

1163.07

First Resistance

1205.27

Second Support

1148.33

Second Resistance

1232.73

Third Support

1120.87

Third Resistance

1247.47

RSI

44.92

ADX

25.94

MACD

-0.66

Williams % R

-79.81

Commodity Channel Index (CCI)

-104.95

Date

2025-04-30

Week

102283.00

Same Day

184122.00

Month

109892.00

1 Year

0.76

3 Year

0.65

Over 1 Month

-2.75%

down

Over 1 Year

-17.16%

down

Over 3 Months

14.08%

down

Over 3 Years

42.32%

down

Over 6 Months

10.56%

down

Over 5 Years

0.00%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

GLOBAL HEALTH LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
43.27%
Promoter Holdings
33.03%
FII
11.76%
DII
11.92%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Naresh Trehan 8.8725457E7 (33.03%) Shareholding of Promoter and Promoter Group
Dunearn Investments (mauritius) Pte Ltd 3.990099E7 (14.86%) Public Shareholding
Sunil Sachdeva 3.0264524E7 (11.27%) Public Shareholding
Rj Corp Limited 1.7705182E7 (6.59%) Public Shareholding
Government Pension Fund Global 8875661.0 (3.3%) Public Shareholding
Kotak India Eq Contra Fund 7867525.0 (2.93%) Public Shareholding
Invesco India Aggressive Hybrid Fund 7409946.0 (2.76%) Public Shareholding
Polaris Healthcare Investments Pte Ltd 5000000.0 (1.86%) Public Shareholding
Canara Robeco Mutual Fund A/c Canara Robeco Emergi 3827661.0 (1.43%) Public Shareholding
Uti-flexi Cap Fund 3179030.0 (1.18%) Public Shareholding
Novo Holdings A/s 2716376.0 (1.01%) Public Shareholding
Rkm Family Trust 1000.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

GLOBAL HEALTH LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

GLOBAL HEALTH LIMITED Share Price

Global Health Limited was incorporated as Global Health Private Limited' on August 13, 2004 at New Delhi, India as a Private Limited Company under the Companies Act, 1956. The Company converted into a Public Limited Company, passed by Shareholders at the EGM held on July 31, 2021 and consequently, name of the Company was changed to Global Health Limited' dated August 11, 2021 issued by the RoC.

The Company was founded by Dr. Naresh Trehan, a world-renowned cardiovascular and cardiothoracic surgeon. The Company is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India in terms of bed capacity with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urologoly. Under the 'Medanta' brand, it has a network of 5 hospitals currently in operation including, Gurugram, Indore, Ranchi, Lucknow and Patna and one hospital in Noida, which is under construction. As at June 30, 2022, the Company provide healthcare services in over 30 medical specialties and is engaged over 1,300 doctors led by experienced department heads and, spanning an area of 4.7 million sq. ft., their operational hospitals have 2,467 installed beds to serve Indian and international patients.

In November 2009, the Company opened its flagship hospital in Gurugram.

In 2015, its subsidiary, Global Health Patliputra Private Limite (GHPPL), entered into a Concession Agreement with Governor of Bihar for the development, operation and maintenance of a proposed hospital on public-private partnership at Patna.

In 2019, it commenced operations of new hospital at Lucknow.

In 2020, Patna hospital's outpatient department facility was launched and the inpatient department facility of its Patna hospital was inaugurated in October 2021, which commenced operations during year 2022.

The Company has taken in-house facility and operate pharmacies at its Gurugram, Lucknow, Indore and Ranchi hospitals as well as launched an outpatient department pharmacy at South Delhi clinic in year 2021 and launched outpatient department pharmacy at South Delhi clinic at Patna hospital in year 2022. As at June 30, 2022, it had 200 installed beds and employed over 50 doctors across key specialties such as neuroscience and cardiac sciences. Patna hospital had 228 installed beds and employed over 125 doctors as at June 30, 2022 and is designed to accommodate over 500 beds.

In the Board Meeting dated 25 January 2021, the Board of Directors of the Holding Company have approved capital raising comprising of fresh issue and offer for sale of equity shares by the existing shareholders through an Initial Public Offering (IPO)

The Company came out with a public issue during November, 2022 by raising Rs. 2205.57 crores through fresh issue amounting to Rs. 500 crores and offer for sale amounting to Rs. 1705.57 crores.

The Company's Lucknow hospital added 191 beds in FY23, including over 90 critical care beds. Lucknow hospital also added seven new OTs and have hired over 50 senior clinicians. Towards the end of FY23, Lucknow hospital commissioned the Siemens Varian EDGE Radiation Oncology machine - the first in North India - as well as set up a dedicated e-ICU Command Centre to assist in remote critical care management. The Company's Patna hospital added over 100 beds and 35+ doctors in FY23. In FY23, the Company also announced a new 300- bed hospital project in Indore under the asset-light O&M model. It started Medanta Labs in January 2023. During the year 2022-23, GHL Pharma was incorporated as a wholly-owned subsidiary on June 29, 2022.

Parent organization Indian Private
NSE symbol MEDANTA
Founded 2004
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Global Health Ltd?

Answer Field

The share price of Global Health Ltd for NSE is ₹ 1197.2 and for BSE is ₹ 1200.

What is the Market Cap of Global Health Ltd?

Answer Field

The market cap of Global Health Ltd for NSE is ₹ 3,03,15.97 Cr. and for BSE is ₹ 3,03,86.87 Cr. as of now.

What is the 52 Week High and Low of Global Health Ltd?

Answer Field

The 52 Week High and Low of Global Health Ltd for NSE is ₹ 1511.00 and ₹ 935.50 and for BSE is ₹ 1510.10 and ₹ 936.05.

How to Buy Global Health Ltd share?

Answer Field

You can trade in Global Health Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Global Health Ltd?

Answer Field

The 1 year returns on the stock has been -17.16%.

What is the Current Share Price of Global Health Ltd?

Answer Field

Global Health Ltd share price is for NSE ₹ 1197.2 & for BSE ₹ 1200 as on Apr 30 2025 03:30 PM.

What is the Market Cap of Global Health Ltd Share?

Answer Field

The market cap of Global Health Ltd for NSE ₹ 3,03,15.97 & for BSE ₹ 3,03,86.87 as on Apr 30 2025 03:30 PM.

What is the P/E Ratio of Global Health Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for Global Health Ltd share is 82.03.

What is the PB ratio of Global Health Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for Global Health Ltd share is 113.49.

How to Buy Global Health Ltd Share?

Answer Field

You can trade in Global Health Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Global Health Ltd Share on Bajaj Broking App?

Answer Field

To buy Global Health Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Global Health Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|